MTOR and leukemia: To further our understanding of Ki-67 ̄ leukaemia cells, particularly with regard to their metabolic activity and hence potential susceptibility to therapeutic inhibition of this activity, we have measured biomarkers of mTOR activation status in presentation samples, using flow cytometry.